BCL2 and prostate neoplasm: Similar to observations of AR and IGF-1 expression, levels of the anti-apoptotic protein BCL-2 and the ratio of BCL-2/BAX, a marker of prostate tumor proliferative potential, were higher in animals submitted to the CS protocol than in all other groups (Figure 4A to D, I, K).